Penmenvy Dosage
Generic name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 5ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 5ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 5ug in 0.5mL; NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE 25ug in 0.5mL
Dosage form: injectable suspension, intramuscular
Drug class: Bacterial vaccines
Medically reviewed by Drugs.com. Last updated on Feb 14, 2025.
For intramuscular use.
Preparation
PENMENVY is supplied as one vial of Lyophilized MenACWY Component (powder) and one prefilled syringe of MenB Component (liquid) which must be combined before administration.
Use only the supplied MenB Component to reconstitute the Lyophilized MenACWY Component.
More about Penmenvy (meningococcal group acwy conjugate-group b vaccine (cvx 328))
- Check interactions
- Compare alternatives
- Side effects
- FDA approval history
- Drug class: bacterial vaccines
Patient resources
Professional resources
Related treatment guides
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.